Health Systems Innovation Council Meeting – Q3 2025

Dr. Joe W. Ramos, PhD became the President and CEO of The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center in early 2025. TLI is a leading nonprofit biomedical research organization in Los Angeles dedicated to advancing medical research, delivering on our mission to improve patient outcomes through cutting-edge research, education, and community engagement.

Previously, Dr. Ramos was the Director and CEP of the Louisiana Cancer Research Center (LCRC) and Director of the Louisiana State University LCMC Health Cancer Center in New Orleans. Before his time in Louisiana, he was the Interim Director at the University of Hawai’i Cancer Center (an NCI-designated Cancer Center), where he served more than 10 years in various leadership roles through two renewals of NCI designation.

Dr. Ramos grew up in a small town in Virginia and completed his undergraduate degree and his PhD at the University of Virginia Medical School. He went on to do postdoctoral studies at the Scripps Research Institute in La Jolla, CA. Driven by a passion for research that makes a difference in people’s lives, he works to assemble and lead formidable teams to conduct groundbreaking research, deliver exceptional clinical care, foster education, and engage with communities, all dedicated to addressing the unique needs of local populations.

source: https://lundquist.org/profile/joe-w-ramos-phd/

Dave Morony joined Casa Colina Hospital and Centers for Healthcare as the Chief Financial Officer in June 2012. He is responsible for overseeing the financial and business affairs of Casa Colina. He has more than 30 years of experience in healthcare accounting, auditing, reimbursement, and consulting. Morony spent the first seven years of his career at KPMG Certified Public Accountants. Immediately prior to joining Casa Colina, he spent 17 years at Ashtabula County Medical Center (an affiliate of the Cleveland Clinic), where he was both the Chief Financial Officer and a Vice President. Morony received his Bachelor of Science degree with a major in Accounting from West Virginia University in 1987 and is a Certified Public Accountant.

Travis True is a senior leader responsible for Oracle Health clients across North America who have a vested interest in their Consumer, Value-Based care strategy, and AI. Travis has been a leader in Oracle for the past five years and has been in the healthcare industry for the previous twenty years.

Throughout his career, Travis has held leadership roles at industry-leading organizations, including Oracle, Vista Equity Partners, and DaVita. His experience spans a wide range of healthcare domains, including health networks, information technology, and consumer engagement. This breadth of knowledge enables him to develop innovative solutions that address the evolving needs of healthcare providers, payers, and patients.

Travis graduated magna cum laude from the University of Arizona with a BS in Aerospace Engineering and a minor in MIS. He received his MBA from the University of California, Irvine, where he studied Healthcare Management and Policy.

As a dedicated advocate for the power of healthcare technology, Travis is committed to fostering a healthier future for individuals and communities worldwide. His work embodies a steadfast belief in the potential of innovation to transform lives and create a more equitable healthcare system.

Travis currently lives in Sedona, Arizona, with his wife and 2-year-old son.

Sam Juraschka is a Partner at BCG X, where she helps healthcare organizations — especially provider systems — build and scale innovation functions. She has led digital transformation and venture-building efforts across top U.S. hospitals, with a focus on data strategy, virtual care, and digital infrastructure. Sam also advises on commercialization, data governance, and AI-driven care models, drawing from experience across provider, payer, and life sciences ecosystems.

I build and scale consumer health businesses by combining breakthrough products, rigorous evidence, and targeted distribution. At Ready, Set, Food!, I pioneered the food allergy prevention category, transforming a novel idea based on clinical studies into a national wellness brand that reached 200k+ families, generated $20M+ in online/Amazon sales, $7M+ in retail (Target, Walmart, Meijer, Wegmans, Sprouts), and secured multiple Medicaid contracts with >25% opt-in among eligible new parents.

I raised $37M from leading strategics and investors, including Johnson & Johnson, Kenvue, Danone, Providence Health, and Memorial Hermann; earned US/EU patents; appeared twice on Shark Tank; and helped lead a 1,100-baby clinical trial proving the ROI of food allergy prevention. We launched partnerships with 15 large health systems to implement fully automated EMR integrations delivering food allergy education to parents (Providence, Advocate Aurora, Northwell, Trinity, Memorial Hermann, and more) and helped pass legislation mandating insurance coverage for early allergen introduction in Delaware, with similar bills advancing in other states.

Earlier in my career, I led corporate strategy at AECOM, driving enterprise-wide planning and board reporting; built go-to-market and growth operations at OpenX; and led strategy and sales/product operations at The Wonderful Company/Teleflora. I also founded a B2B dental supply distribution company, scaling to 45 employees and $10M in annual revenue.

Focus areas: omnichannel consumer healthcare GTM (retail, Amazon, DTC, provider engagement), payer reimbursement (Medicaid, commercial, employer), clinical partnerships, value creation and turnarounds, and P&L leadership. I advise founders and investors and seek Advisory, Board, or operational opportunities where my track record in scaling consumer and B2B health businesses can accelerate growth and impact.

Before BDI, Jonathan Taub was President of Sequoia/Tencent-backed medical image AI company VoxelCloud Inc., EVP of IP licensing company Acacia Research (helping grow Acacia’s market cap from $90 million to $2 billion in less than 5 years) and was the co-founder and CEO of ARCH-backed biopharma company Epirium Bio (previously Cardero Therapeutics).

He was previously director of strategic alliances at Microsoft and director of business development at Nortel Networks following Nortel’s $450M acquisition of cloud software pioneer Epicon, where he headed business development.

He is a Wharton (University of Pennsylvania) and Harvard Law School graduate.